Jose Munoz

Five Years Of Activity In A Priority Sector: The European Commission's Report On Competition Enforcement In The Pharmaceutical Sector (2018-2022)

Another Chapter In The "Pay For Delay" Saga: General Court Rules On The Teva-Cephalon Settlement Agreement

Peru Adopts New Leniency Regime With Significant Changes For Leniency Applicants

Competition Law Developments In The Pharma Sector – 2022 Round-up And What To Expect In 2023

Sanction Imposed By The Spanish Competition Authority On A Pharma Company For Misusing Litigation Strategies Regarding Patents

Update On The Teva Copaxone EU Case. The EU Commission Issues A Statement Of Objections Against Teva Over Alleged Anti-competitive Conduct Consisting Of Misuse Of Divisional Patents And A Disparagement Campaign Against Its Closest Competitor

The FNE's Gun-Jumping Investigation Into GSK's Acquisition Of Pfizer's Consumer Healthcare Business In Chile: When A Joint Venture Is Not A Joint Venture And Why It Matters